A Brief Review on Inflammatory Mediators and Drug Therapy for Rheumatoid Arthritis

Authors

  • Puja Kumari Rai
  • Vimukta Sharma
  • Jayanti Mukharjee
  • Vipin V Dhote

DOI:

https://doi.org/10.37591/tdd.v6i2.610

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease which is characterized by inflammation of the joints and destruction of cartilage and bone. The disease pathology is complex which involves the infiltration and activation of various populations of immune cells along with the release of destructive inflammatory mediators into the synovium of affected joints. Several inflammatory mediators are involved in just like IL-1, IL-6, IL-8, IL-17, IL-18 and tumour necrosis factor-alfa. Treatment of Rheumatoid arthritis used to Small molecules and biological modifiers such as DMARDs, Methotrexate, Gold, Corticosteroids, analgesic and TNF-α blockers an IL-1 antagonist.

 

Keywords: Autoimmune, pathology, immune, small molecules, biological modifiers

 

Cite this Article

Puja Kumari Rai, Vimukta Sharma, Jayanti Mukharjee, Vipin V. Dhote. A Brief Review on Inflammatory Mediators and Drug Therapy for Rheumatoid Arthritis. Trends in Drug Delivery. 2019; 6(2): 1–4p.

 

Downloads

Published

2019-09-27

Issue

Vol. 6 No. 2 (2019)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.